tcdB positive (N = 97) | tcdB negative (N = 863) | P | |
---|---|---|---|
Age, median (95% CIa) | 1.6 (1.4–2.2) | 3.8 (3.3–4.5) | < 0.01 |
Age group (N) | |||
0 (219) | |||
Inpatient | 12 | 140 | 0.09 |
Outpatient | 11 | 56 | |
Subtotal | 23 | 196 | |
1 (153) | |||
Inpatient | 18 | 95 | 0.16 |
Outpatient | 11 | 29 | |
Subtotal | 29 | 124 | |
2–6 (265) | |||
Inpatient | 11 | 204 | < 0.01 |
Outpatient | 15 | 61 | |
Subtotal | 26 | 239 | |
7–12 (171) | |||
Inpatient | 7 | 137 | 0.42 |
Outpatient | 3 | 34 | |
Subtotal | 10 | 161 | |
13–18 (152) | |||
Inpatient | 9 | 125 | 0.36 |
Outpatient | 0 | 27 | |
Subtotal | 9 | 143 | |
Total (960) | |||
Inpatient | 57 | 674 | < 0.01 |
Outpatient | 40 | 189 | |
Subtotal | 97 | 863 | |
Sex | 0.64 | ||
Male | 54 | 502 | |
Female | 43 | 361 | |
Length of stay at testing, median (95% CI) | 5 (3.6–6.0) | 4 (4.0–5.0) | 0.807 |
30-day mortality | 2 | 10 | 0.346 |
Other gastrointestinal pathogens | |||
Detected | 30 | 295 | 0.52 |
Not detected | 67 | 568 |